                               SEQUENCE LISTING

<110> AbbVie Deutschland GmbH & Co. KG
 
<120> SURFACE-MODIFIED NANOSPHERES ENCAPSULATING ANTIGEN-BINDING MOLECULES 

<130> M/56206-PCT

<150> US 62/258,077
<151> 2015-11-20

<160> 4

<210> 1
<211> 25
<212> PRT
<213> Homo sapiens

<400> 1
Tyr Leu Arg Val Arg Leu Ala Ser His Leu Arg Lys Leu Arg Lys Arg 
1               5                   10                  15      


Leu Leu Arg Asp Ala Asp Asp Leu Tyr 
            20                  25  


<210> 2
<211> 29
<212> PRT
<213> Rabies virus

<400> 2
Tyr Thr Ile Trp Met Pro Glu Asn Pro Arg Pro Gly Thr Pro Cys Asp 
1               5                   10                  15      


Ile Phe Thr Asn Ser Arg Gly Lys Arg Ala Ser Asn Gly 
            20                  25                  


<210> 3
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223>  synthetic

<400> 3
Thr Phe Phe Tyr Gly Gly Ser Arg Gly Lys Arg Asn Asn Phe Lys Thr 
1               5                   10                  15      


Glu Glu Tyr 
            


<210> 4
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<223>  synthetic

<400> 4
Tyr Thr Ile Trp Met Pro Glu Asn Pro Arg Pro Gly Thr Pro Cys Asp 
1               5                   10                  15      


Ile Phe Thr Asn Ser Arg Gly Lys Arg Ala Ser Asn Gly Cys 
            20                  25                  30  

